<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&amp;ev=PageView&amp;noscript=1">
Compliance In Focus
Posted by John Lehmann on Fri, Oct 17, 2014

IMARC Signs Agreement with European CRO

IMARC Research and TheraGenesis GmbH of Sutensee, Germany have signed a IMARC Signs Agreement with European CROcollaboration agreement to integrate and expand their combined resources, services and expertise in the development of medical devices. The agreement is solely a work-based collaboration with neither firm holding a financial stake in the other.

The agreement expands IMARC's reach to include most European countries, helping to make it faster, easier and less costly for IMARC's U.S.-based to attain European approval.  The companies released a Press Release announcing the collaboration.

If you have any questions regarding the collaboration, please do not hesitate to contact us.

Photo Credit: Richard Busch

 FDA Regs vs ISO Whitepaper



Topics: European CRO, TheraGenesis GmbH, IMARC Research


Posts by Topic: